How to read a peptide certificate of analysis

A peptide certificate of analysis (COA) records particular tests on a submitted sample. To interpret it, connect three things: the material described, the measurements reported, and the batch relationship. A high purity number cannot answer all three questions.

This guide explains how to read laboratory documentation. It does not establish that a product is suitable for human or veterinary use.

Sources checked October 7, 2026; public report-library examples checked October 8, 2026.

1. Identify the sample before reading the result

Start with the report identifier, sample name, material, labeled amount, batch number and testing date. Keep a report number separate from a batch number: the first identifies a document or testing task; the second is intended to connect material to a production lot. A familiar product name alone is not a stock-to-batch link.

Also distinguish a header from an analytical finding. Janoshik explains that clients enter report-header details such as sample name, manufacturer and batch number. Those fields help trace the submission, but their presence alone does not independently establish the supplier’s manufacturing history or the contents of every vial bearing that label. Read the laboratory’s explanation of report headers.

• Match the exact material, including a named salt, complex or fragment where stated.
• Match the labeled amount and whether the sample is a single compound or a blend.
• Check whether the batch identifier is present and matches the relevant inventory record.
• Record missing information as unknown. Do not fill a blank from a similar listing.

Appearance is an observation to document, not an identity assay. If you are comparing blue vials, see Why is my GHK-Cu a different shade of blue? before inferring purity or content from a photograph.

2. Separate amount, purity and other tests

Read the measurement name, method and unit together. A percentage and a mass per vial describe different properties. The meaning of a percentage depends on its stated basis.

For Janoshik reports, the laboratory defines peptide purity in relation to the peptide content and distinguishes it from mass/mass purity of raw powder. It also states that peptide purity is not provided for blends because the components can interfere with that measurement. A blend’s content results should not be turned into an invented combined purity percentage. Other laboratories may use different reporting conventions; check the issuer’s definition. Janoshik’s purity definitions.

Janoshik describes TAMC/TYMC results in terms of colonies detected after cultivation, and describes endotoxin testing as a separate assay for lipopolysaccharide. Preserve those scopes. A report heading containing the word “sterility” does not justify expanding its stated method into a guarantee about all units or all possible contamination. Microbiological result definitions; endotoxin analysis.

If a result is absent, the supplied document does not establish that property. This is different from claiming that no such test has ever been performed. If a value is below a reporting limit or is an estimate, retain that qualification instead of rewriting it as zero.

For a worked example of separate purity, microbiological and endotoxin findings, see Does 99% peptide purity mean my vial is sterile? Keep missing tests and method-specific results distinct.

3. Verify the document and its relationship to the material

When the laboratory provides a verification service, open the issuer’s record and compare it with the copy being presented. For Janoshik, verification uses a task number and unique key; its guidance says both are needed. Compare the actual report, including findings and identifiers, rather than relying on the existence of a QR code. Laboratory report-verification instructions.

A redacted copy may withhold the information needed for this comparison. Record the verification limit and request the applicable complete record through the existing documentation process. A genuine report and a demonstrated link to current inventory are separate checks. Neither a working PDF link nor an authentic report, by itself, confirms which batch is currently offered.

4. Read real report-library examples without extending their scope

The following identifiers are shown in the Serum Research report library. They illustrate how to match documentation fields. They are library-record examples, not a claim that these reports cover Peptide Serum inventory or any batch currently being shipped. No numerical assay result is inferred from a library card.

5. Record a conclusion that preserves the gaps

Use a short record that another reader can check:

• Material: exact name, form and labeled amount.
• Document: laboratory, report identifier, date and original link.
• Sample and batch: exactly what the record states.
• Results: each test, its reported value or finding, unit and qualification.
• Verification: issuer record matched, unavailable, or not yet checked.
• Inventory relationship: documented current match, historical record, or unknown.
• Missing information: facts the available record does not establish.

A defensible conclusion can be modest: “A report for this material and labeled amount is available; its connection to current stock has not been established.” Avoid replacing that with “every batch tested,” “completely pure,” or a medical-safety claim.

For Peptide Serum’s existing documentation-request process, see Lab Testing. To assess a scientific claim rather than a laboratory report, use Preclinical and human peptide research: how to read the evidence. A COA and a research paper answer different questions.

Material and exact form:
Labeled amount and pack contents:
Laboratory / report identifier / report date:
Original report URL and date checked:
Submitted sample identifier:
Report batch / offered-stock batch:
Identity finding and method:
Amount finding, unit and qualification:
Purity finding and stated reporting basis:
Other tests, units and reporting limits:
Issuer-record verification status:
Record connecting sample to current stock:
Missing information / next document needed:
Conclusion supported by this record: